nodes	percent_of_prediction	percent_of_DWPC	metapath
Desipramine—SLC22A3—Progesterone—uterine cancer	0.155	0.214	CbGbCtD
Desipramine—SLC22A2—Progesterone—uterine cancer	0.0918	0.127	CbGbCtD
Desipramine—SLC22A1—Progesterone—uterine cancer	0.0797	0.11	CbGbCtD
Desipramine—SLC22A5—Dactinomycin—uterine cancer	0.0763	0.106	CbGbCtD
Desipramine—CYP2A6—Progesterone—uterine cancer	0.0732	0.101	CbGbCtD
Desipramine—CYP2C19—Progesterone—uterine cancer	0.0303	0.0419	CbGbCtD
Desipramine—CYP1A2—Progesterone—uterine cancer	0.0279	0.0386	CbGbCtD
Desipramine—ABCB1—Progesterone—uterine cancer	0.0244	0.0338	CbGbCtD
Desipramine—CYP2D6—Progesterone—uterine cancer	0.023	0.0318	CbGbCtD
Desipramine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0221	0.0305	CbGbCtD
Desipramine—CYP2E1—Etoposide—uterine cancer	0.0216	0.0299	CbGbCtD
Desipramine—ABCB1—Dactinomycin—uterine cancer	0.0194	0.0268	CbGbCtD
Desipramine—CYP3A4—Progesterone—uterine cancer	0.0146	0.0202	CbGbCtD
Desipramine—CYP2B6—Doxorubicin—uterine cancer	0.0145	0.0201	CbGbCtD
Desipramine—CYP1A2—Etoposide—uterine cancer	0.0125	0.0173	CbGbCtD
Desipramine—ABCB1—Etoposide—uterine cancer	0.0109	0.0151	CbGbCtD
Desipramine—CHRM3—ureter—uterine cancer	0.00938	0.114	CbGeAlD
Desipramine—ABCB1—Doxorubicin—uterine cancer	0.00746	0.0103	CbGbCtD
Desipramine—CYP2D6—Doxorubicin—uterine cancer	0.00703	0.00971	CbGbCtD
Desipramine—CHRM3—muscle of abdomen—uterine cancer	0.00676	0.082	CbGeAlD
Desipramine—CYP3A4—Etoposide—uterine cancer	0.00655	0.00906	CbGbCtD
Desipramine—CYP3A4—Doxorubicin—uterine cancer	0.00447	0.00618	CbGbCtD
Desipramine—SMPD1—decidua—uterine cancer	0.00204	0.0248	CbGeAlD
Desipramine—SMPD1—renal system—uterine cancer	0.00201	0.0244	CbGeAlD
Desipramine—CHRM3—exocrine gland—uterine cancer	0.00185	0.0225	CbGeAlD
Desipramine—CYP2C18—uterine cervix—uterine cancer	0.00174	0.0212	CbGeAlD
Desipramine—SMPD1—female reproductive system—uterine cancer	0.00161	0.0195	CbGeAlD
Desipramine—CYP2C18—mammalian vulva—uterine cancer	0.00153	0.0185	CbGeAlD
Desipramine—SMPD1—female gonad—uterine cancer	0.00146	0.0177	CbGeAlD
Desipramine—SMPD1—vagina—uterine cancer	0.00145	0.0176	CbGeAlD
Desipramine—CHRM5—epithelium—uterine cancer	0.00144	0.0175	CbGeAlD
Desipramine—SLC22A4—myometrium—uterine cancer	0.0013	0.0158	CbGeAlD
Desipramine—SLC22A2—renal system—uterine cancer	0.00127	0.0155	CbGeAlD
Desipramine—HTR2A—artery—uterine cancer	0.00126	0.0153	CbGeAlD
Desipramine—CYP2C18—vagina—uterine cancer	0.00118	0.0143	CbGeAlD
Desipramine—SLC22A3—myometrium—uterine cancer	0.00118	0.0143	CbGeAlD
Desipramine—SLC22A4—decidua—uterine cancer	0.000962	0.0117	CbGeAlD
Desipramine—ORM1—endometrium—uterine cancer	0.00095	0.0115	CbGeAlD
Desipramine—SLC22A4—renal system—uterine cancer	0.000945	0.0115	CbGeAlD
Desipramine—SMPD1—lymph node—uterine cancer	0.00094	0.0114	CbGeAlD
Desipramine—SLC22A3—uterine cervix—uterine cancer	0.000919	0.0112	CbGeAlD
Desipramine—SLC22A4—endometrium—uterine cancer	0.000913	0.0111	CbGeAlD
Desipramine—SLC22A1—renal system—uterine cancer	0.0009	0.0109	CbGeAlD
Desipramine—SLC22A3—smooth muscle tissue—uterine cancer	0.000893	0.0108	CbGeAlD
Desipramine—SLC22A3—renal system—uterine cancer	0.00086	0.0104	CbGeAlD
Desipramine—SLC22A5—myometrium—uterine cancer	0.000859	0.0104	CbGeAlD
Desipramine—SLC22A3—endometrium—uterine cancer	0.000831	0.0101	CbGeAlD
Desipramine—SLC22A3—mammalian vulva—uterine cancer	0.000804	0.00976	CbGeAlD
Desipramine—ORM1—female reproductive system—uterine cancer	0.000787	0.00955	CbGeAlD
Desipramine—CYP2A6—vagina—uterine cancer	0.000781	0.00948	CbGeAlD
Desipramine—CHRM3—smooth muscle tissue—uterine cancer	0.000775	0.00941	CbGeAlD
Desipramine—SLC22A4—female reproductive system—uterine cancer	0.000757	0.00919	CbGeAlD
Desipramine—SLC6A2—decidua—uterine cancer	0.00075	0.00911	CbGeAlD
Desipramine—CHRM3—renal system—uterine cancer	0.000746	0.00906	CbGeAlD
Desipramine—HTR1A—renal system—uterine cancer	0.000743	0.00902	CbGeAlD
Desipramine—HRH1—myometrium—uterine cancer	0.000728	0.00884	CbGeAlD
Desipramine—HTR2C—female reproductive system—uterine cancer	0.000707	0.00859	CbGeAlD
Desipramine—ADRB1—female reproductive system—uterine cancer	0.000694	0.00842	CbGeAlD
Desipramine—SLC22A3—female reproductive system—uterine cancer	0.000689	0.00836	CbGeAlD
Desipramine—SLC22A4—vagina—uterine cancer	0.000684	0.00831	CbGeAlD
Desipramine—SLC6A4—female reproductive system—uterine cancer	0.00067	0.00814	CbGeAlD
Desipramine—SLC22A5—uterine cervix—uterine cancer	0.000668	0.00812	CbGeAlD
Desipramine—CHRM1—female reproductive system—uterine cancer	0.000668	0.00811	CbGeAlD
Desipramine—SLC22A1—vagina—uterine cancer	0.000652	0.00791	CbGeAlD
Desipramine—SLC22A3—female gonad—uterine cancer	0.000627	0.00761	CbGeAlD
Desipramine—SLC22A5—renal system—uterine cancer	0.000625	0.00759	CbGeAlD
Desipramine—SLC22A3—vagina—uterine cancer	0.000623	0.00756	CbGeAlD
Desipramine—Hypertension—Progesterone—uterine cancer	0.000607	0.00439	CcSEcCtD
Desipramine—SLC22A5—endometrium—uterine cancer	0.000604	0.00734	CbGeAlD
Desipramine—CHRM3—female reproductive system—uterine cancer	0.000598	0.00726	CbGeAlD
Desipramine—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000597	0.00431	CcSEcCtD
Desipramine—Anxiety—Progesterone—uterine cancer	0.000597	0.00431	CcSEcCtD
Desipramine—Agranulocytosis—Dactinomycin—uterine cancer	0.000594	0.00429	CcSEcCtD
Desipramine—Discomfort—Progesterone—uterine cancer	0.000592	0.00427	CcSEcCtD
Desipramine—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000591	0.00427	CcSEcCtD
Desipramine—SLC6A2—female reproductive system—uterine cancer	0.00059	0.00717	CbGeAlD
Desipramine—Agitation—Medroxyprogesterone Acetate—uterine cancer	0.000586	0.00423	CcSEcCtD
Desipramine—Dry mouth—Progesterone—uterine cancer	0.000586	0.00423	CcSEcCtD
Desipramine—Confusional state—Progesterone—uterine cancer	0.000579	0.00418	CcSEcCtD
Desipramine—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000575	0.00415	CcSEcCtD
Desipramine—Oedema—Progesterone—uterine cancer	0.000574	0.00415	CcSEcCtD
Desipramine—HRH1—epithelium—uterine cancer	0.000572	0.00694	CbGeAlD
Desipramine—Hepatitis—Dactinomycin—uterine cancer	0.000571	0.00412	CcSEcCtD
Desipramine—HRH1—uterine cervix—uterine cancer	0.000567	0.00688	CbGeAlD
Desipramine—CYP1A2—renal system—uterine cancer	0.000566	0.00688	CbGeAlD
Desipramine—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000563	0.00407	CcSEcCtD
Desipramine—Petechiae—Epirubicin—uterine cancer	0.000561	0.00405	CcSEcCtD
Desipramine—Tachycardia—Progesterone—uterine cancer	0.00056	0.00405	CcSEcCtD
Desipramine—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00399	CcSEcCtD
Desipramine—HRH1—smooth muscle tissue—uterine cancer	0.000551	0.00669	CbGeAlD
Desipramine—Anorexia—Progesterone—uterine cancer	0.000547	0.00395	CcSEcCtD
Desipramine—CHRM3—female gonad—uterine cancer	0.000544	0.0066	CbGeAlD
Desipramine—CYP2B6—renal system—uterine cancer	0.000543	0.00659	CbGeAlD
Desipramine—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000541	0.00391	CcSEcCtD
Desipramine—HRH1—decidua—uterine cancer	0.00054	0.00656	CbGeAlD
Desipramine—Hypotension—Progesterone—uterine cancer	0.000536	0.00387	CcSEcCtD
Desipramine—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000536	0.00387	CcSEcCtD
Desipramine—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000531	0.00383	CcSEcCtD
Desipramine—Flushing—Dactinomycin—uterine cancer	0.00053	0.00383	CcSEcCtD
Desipramine—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.000525	0.00379	CcSEcCtD
Desipramine—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.00052	0.00376	CcSEcCtD
Desipramine—Insomnia—Progesterone—uterine cancer	0.000519	0.00375	CcSEcCtD
Desipramine—Petechiae—Doxorubicin—uterine cancer	0.000519	0.00375	CcSEcCtD
Desipramine—Paraesthesia—Progesterone—uterine cancer	0.000516	0.00372	CcSEcCtD
Desipramine—HRH1—endometrium—uterine cancer	0.000513	0.00622	CbGeAlD
Desipramine—Ventricular extrasystoles—Epirubicin—uterine cancer	0.000511	0.00369	CcSEcCtD
Desipramine—Somnolence—Progesterone—uterine cancer	0.00051	0.00369	CcSEcCtD
Desipramine—CYP2E1—renal system—uterine cancer	0.00051	0.00619	CbGeAlD
Desipramine—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.000509	0.00368	CcSEcCtD
Desipramine—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000508	0.00367	CcSEcCtD
Desipramine—Dyspepsia—Progesterone—uterine cancer	0.000505	0.00365	CcSEcCtD
Desipramine—Alopecia—Dactinomycin—uterine cancer	0.000505	0.00364	CcSEcCtD
Desipramine—CYP2C19—vagina—uterine cancer	0.000502	0.0061	CbGeAlD
Desipramine—SLC22A5—female reproductive system—uterine cancer	0.000501	0.00608	CbGeAlD
Desipramine—Decreased appetite—Progesterone—uterine cancer	0.000499	0.0036	CcSEcCtD
Desipramine—Nocturia—Epirubicin—uterine cancer	0.000497	0.00359	CcSEcCtD
Desipramine—HRH1—mammalian vulva—uterine cancer	0.000496	0.00602	CbGeAlD
Desipramine—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000496	0.00358	CcSEcCtD
Desipramine—Fatigue—Progesterone—uterine cancer	0.000495	0.00357	CcSEcCtD
Desipramine—Constipation—Progesterone—uterine cancer	0.000491	0.00355	CcSEcCtD
Desipramine—Hypotension—Medroxyprogesterone Acetate—uterine cancer	0.000486	0.00351	CcSEcCtD
Desipramine—HTR2A—epithelium—uterine cancer	0.000477	0.0058	CbGeAlD
Desipramine—Atrioventricular block—Epirubicin—uterine cancer	0.000476	0.00343	CcSEcCtD
Desipramine—Feeling abnormal—Progesterone—uterine cancer	0.000473	0.00342	CcSEcCtD
Desipramine—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.000473	0.00341	CcSEcCtD
Desipramine—Insomnia—Medroxyprogesterone Acetate—uterine cancer	0.000471	0.0034	CcSEcCtD
Desipramine—Coordination abnormal—Epirubicin—uterine cancer	0.00047	0.00339	CcSEcCtD
Desipramine—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.000467	0.00337	CcSEcCtD
Desipramine—Somnolence—Medroxyprogesterone Acetate—uterine cancer	0.000462	0.00334	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Epirubicin—uterine cancer	0.000461	0.00333	CcSEcCtD
Desipramine—Ventricular tachycardia—Epirubicin—uterine cancer	0.000461	0.00333	CcSEcCtD
Desipramine—Ill-defined disorder—Dactinomycin—uterine cancer	0.000461	0.00333	CcSEcCtD
Desipramine—Nocturia—Doxorubicin—uterine cancer	0.00046	0.00332	CcSEcCtD
Desipramine—ORM1—lymph node—uterine cancer	0.00046	0.00559	CbGeAlD
Desipramine—HTR2A—smooth muscle tissue—uterine cancer	0.00046	0.00559	CbGeAlD
Desipramine—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000458	0.00331	CcSEcCtD
Desipramine—Urticaria—Progesterone—uterine cancer	0.000456	0.00329	CcSEcCtD
Desipramine—SLC22A5—female gonad—uterine cancer	0.000456	0.00553	CbGeAlD
Desipramine—Acute coronary syndrome—Etoposide—uterine cancer	0.000454	0.00328	CcSEcCtD
Desipramine—Abdominal pain—Progesterone—uterine cancer	0.000454	0.00328	CcSEcCtD
Desipramine—Body temperature increased—Progesterone—uterine cancer	0.000454	0.00328	CcSEcCtD
Desipramine—SLC22A5—vagina—uterine cancer	0.000453	0.0055	CbGeAlD
Desipramine—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000452	0.00327	CcSEcCtD
Desipramine—Myocardial infarction—Etoposide—uterine cancer	0.000451	0.00326	CcSEcCtD
Desipramine—Neuropathy peripheral—Etoposide—uterine cancer	0.000451	0.00326	CcSEcCtD
Desipramine—Jaundice—Etoposide—uterine cancer	0.000449	0.00324	CcSEcCtD
Desipramine—Stomatitis—Etoposide—uterine cancer	0.000449	0.00324	CcSEcCtD
Desipramine—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000449	0.00324	CcSEcCtD
Desipramine—Malaise—Dactinomycin—uterine cancer	0.000448	0.00324	CcSEcCtD
Desipramine—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000445	0.00321	CcSEcCtD
Desipramine—HTR2A—renal system—uterine cancer	0.000443	0.00538	CbGeAlD
Desipramine—SLC22A4—lymph node—uterine cancer	0.000443	0.00538	CbGeAlD
Desipramine—Atrioventricular block—Doxorubicin—uterine cancer	0.00044	0.00318	CcSEcCtD
Desipramine—CYP2B6—female reproductive system—uterine cancer	0.000435	0.00528	CbGeAlD
Desipramine—Coordination abnormal—Doxorubicin—uterine cancer	0.000435	0.00314	CcSEcCtD
Desipramine—Agranulocytosis—Etoposide—uterine cancer	0.00043	0.0031	CcSEcCtD
Desipramine—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000429	0.0031	CcSEcCtD
Desipramine—Ventricular tachycardia—Doxorubicin—uterine cancer	0.000427	0.00308	CcSEcCtD
Desipramine—Phosphatase alkaline increased—Doxorubicin—uterine cancer	0.000427	0.00308	CcSEcCtD
Desipramine—HRH1—female reproductive system—uterine cancer	0.000425	0.00516	CbGeAlD
Desipramine—Discomfort—Dactinomycin—uterine cancer	0.000418	0.00302	CcSEcCtD
Desipramine—Urticaria—Medroxyprogesterone Acetate—uterine cancer	0.000413	0.00298	CcSEcCtD
Desipramine—Asthenia—Progesterone—uterine cancer	0.000412	0.00297	CcSEcCtD
Desipramine—Hypoaesthesia—Etoposide—uterine cancer	0.000411	0.00297	CcSEcCtD
Desipramine—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000411	0.00297	CcSEcCtD
Desipramine—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.000411	0.00297	CcSEcCtD
Desipramine—CYP3A4—renal system—uterine cancer	0.00041	0.00498	CbGeAlD
Desipramine—CYP2E1—female reproductive system—uterine cancer	0.000408	0.00496	CbGeAlD
Desipramine—Pruritus—Progesterone—uterine cancer	0.000406	0.00293	CcSEcCtD
Desipramine—Oedema—Dactinomycin—uterine cancer	0.000406	0.00293	CcSEcCtD
Desipramine—CYP2D6—renal system—uterine cancer	0.000403	0.0049	CbGeAlD
Desipramine—SLC22A3—lymph node—uterine cancer	0.000403	0.00489	CbGeAlD
Desipramine—ABCB1—myometrium—uterine cancer	0.000399	0.00484	CbGeAlD
Desipramine—Thrombocytopenia—Dactinomycin—uterine cancer	0.000397	0.00287	CcSEcCtD
Desipramine—CYP2B6—vagina—uterine cancer	0.000393	0.00478	CbGeAlD
Desipramine—Diarrhoea—Progesterone—uterine cancer	0.000393	0.00284	CcSEcCtD
Desipramine—Anorexia—Dactinomycin—uterine cancer	0.000387	0.00279	CcSEcCtD
Desipramine—HRH1—female gonad—uterine cancer	0.000386	0.00469	CbGeAlD
Desipramine—Blood alkaline phosphatase increased—Epirubicin—uterine cancer	0.000385	0.00278	CcSEcCtD
Desipramine—HRH1—vagina—uterine cancer	0.000384	0.00466	CbGeAlD
Desipramine—Flushing—Etoposide—uterine cancer	0.000384	0.00277	CcSEcCtD
Desipramine—Dizziness—Progesterone—uterine cancer	0.00038	0.00274	CcSEcCtD
Desipramine—Vascular purpura—Epirubicin—uterine cancer	0.000374	0.0027	CcSEcCtD
Desipramine—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000373	0.0027	CcSEcCtD
Desipramine—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.000368	0.00266	CcSEcCtD
Desipramine—Alopecia—Etoposide—uterine cancer	0.000365	0.00264	CcSEcCtD
Desipramine—Vomiting—Progesterone—uterine cancer	0.000365	0.00264	CcSEcCtD
Desipramine—Rash—Progesterone—uterine cancer	0.000362	0.00261	CcSEcCtD
Desipramine—Dermatitis—Progesterone—uterine cancer	0.000362	0.00261	CcSEcCtD
Desipramine—Headache—Progesterone—uterine cancer	0.00036	0.0026	CcSEcCtD
Desipramine—Blood alkaline phosphatase increased—Doxorubicin—uterine cancer	0.000356	0.00257	CcSEcCtD
Desipramine—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000356	0.00257	CcSEcCtD
Desipramine—HTR2A—female reproductive system—uterine cancer	0.000355	0.00431	CbGeAlD
Desipramine—Decreased appetite—Dactinomycin—uterine cancer	0.000353	0.00255	CcSEcCtD
Desipramine—Dysgeusia—Etoposide—uterine cancer	0.000352	0.00254	CcSEcCtD
Desipramine—Fatigue—Dactinomycin—uterine cancer	0.00035	0.00253	CcSEcCtD
Desipramine—Purpura—Epirubicin—uterine cancer	0.000348	0.00251	CcSEcCtD
Desipramine—Vascular purpura—Doxorubicin—uterine cancer	0.000346	0.0025	CcSEcCtD
Desipramine—SLC6A2—lymph node—uterine cancer	0.000345	0.00419	CbGeAlD
Desipramine—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000344	0.00248	CcSEcCtD
Desipramine—Cerebrovascular accident—Epirubicin—uterine cancer	0.000342	0.00247	CcSEcCtD
Desipramine—Nausea—Progesterone—uterine cancer	0.000341	0.00246	CcSEcCtD
Desipramine—Feeling abnormal—Dactinomycin—uterine cancer	0.000334	0.00241	CcSEcCtD
Desipramine—Ill-defined disorder—Etoposide—uterine cancer	0.000334	0.00241	CcSEcCtD
Desipramine—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000331	0.00239	CcSEcCtD
Desipramine—CYP3A4—female reproductive system—uterine cancer	0.000328	0.00399	CbGeAlD
Desipramine—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000328	0.00237	CcSEcCtD
Desipramine—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000328	0.00237	CcSEcCtD
Desipramine—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000326	0.00235	CcSEcCtD
Desipramine—Malaise—Etoposide—uterine cancer	0.000324	0.00234	CcSEcCtD
Desipramine—CYP2D6—female reproductive system—uterine cancer	0.000323	0.00392	CbGeAlD
Desipramine—Purpura—Doxorubicin—uterine cancer	0.000322	0.00232	CcSEcCtD
Desipramine—Body temperature increased—Dactinomycin—uterine cancer	0.000321	0.00232	CcSEcCtD
Desipramine—Abdominal pain—Dactinomycin—uterine cancer	0.000321	0.00232	CcSEcCtD
Desipramine—HTR2A—vagina—uterine cancer	0.000321	0.0039	CbGeAlD
Desipramine—Cerebrovascular accident—Doxorubicin—uterine cancer	0.000316	0.00228	CcSEcCtD
Desipramine—Ataxia—Epirubicin—uterine cancer	0.000315	0.00227	CcSEcCtD
Desipramine—ABCB1—epithelium—uterine cancer	0.000313	0.0038	CbGeAlD
Desipramine—Convulsion—Etoposide—uterine cancer	0.000312	0.00225	CcSEcCtD
Desipramine—Hypertension—Etoposide—uterine cancer	0.000311	0.00224	CcSEcCtD
Desipramine—ABCB1—uterine cervix—uterine cancer	0.00031	0.00377	CbGeAlD
Desipramine—Liver function test abnormal—Epirubicin—uterine cancer	0.000309	0.00223	CcSEcCtD
Desipramine—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000309	0.00223	CcSEcCtD
Desipramine—Discomfort—Etoposide—uterine cancer	0.000303	0.00219	CcSEcCtD
Desipramine—Confusional state—Etoposide—uterine cancer	0.000296	0.00214	CcSEcCtD
Desipramine—ABCB1—decidua—uterine cancer	0.000296	0.00359	CbGeAlD
Desipramine—CYP2D6—female gonad—uterine cancer	0.000294	0.00357	CbGeAlD
Desipramine—SLC22A5—lymph node—uterine cancer	0.000293	0.00356	CbGeAlD
Desipramine—Ataxia—Doxorubicin—uterine cancer	0.000291	0.0021	CcSEcCtD
Desipramine—Asthenia—Dactinomycin—uterine cancer	0.000291	0.0021	CcSEcCtD
Desipramine—ABCB1—renal system—uterine cancer	0.00029	0.00352	CbGeAlD
Desipramine—Thrombocytopenia—Etoposide—uterine cancer	0.000288	0.00208	CcSEcCtD
Desipramine—Tachycardia—Etoposide—uterine cancer	0.000287	0.00207	CcSEcCtD
Desipramine—Eosinophilia—Epirubicin—uterine cancer	0.000287	0.00207	CcSEcCtD
Desipramine—Liver function test abnormal—Doxorubicin—uterine cancer	0.000286	0.00207	CcSEcCtD
Desipramine—ABCB1—endometrium—uterine cancer	0.000281	0.00341	CbGeAlD
Desipramine—Anorexia—Etoposide—uterine cancer	0.00028	0.00202	CcSEcCtD
Desipramine—Diarrhoea—Dactinomycin—uterine cancer	0.000278	0.002	CcSEcCtD
Desipramine—Hypotension—Etoposide—uterine cancer	0.000274	0.00198	CcSEcCtD
Desipramine—ABCB1—mammalian vulva—uterine cancer	0.000271	0.0033	CbGeAlD
Desipramine—Pollakiuria—Epirubicin—uterine cancer	0.000267	0.00193	CcSEcCtD
Desipramine—Eosinophilia—Doxorubicin—uterine cancer	0.000265	0.00192	CcSEcCtD
Desipramine—Paraesthesia—Etoposide—uterine cancer	0.000264	0.0019	CcSEcCtD
Desipramine—Weight increased—Epirubicin—uterine cancer	0.000263	0.0019	CcSEcCtD
Desipramine—Somnolence—Etoposide—uterine cancer	0.000261	0.00189	CcSEcCtD
Desipramine—ABCB1—uterus—uterine cancer	0.000259	0.00314	CbGeAlD
Desipramine—Drowsiness—Epirubicin—uterine cancer	0.000258	0.00186	CcSEcCtD
Desipramine—Vomiting—Dactinomycin—uterine cancer	0.000258	0.00186	CcSEcCtD
Desipramine—Rash—Dactinomycin—uterine cancer	0.000256	0.00185	CcSEcCtD
Desipramine—Decreased appetite—Etoposide—uterine cancer	0.000255	0.00184	CcSEcCtD
Desipramine—Fatigue—Etoposide—uterine cancer	0.000253	0.00183	CcSEcCtD
Desipramine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000253	0.00183	CcSEcCtD
Desipramine—Stomatitis—Epirubicin—uterine cancer	0.000252	0.00182	CcSEcCtD
Desipramine—Jaundice—Epirubicin—uterine cancer	0.000252	0.00182	CcSEcCtD
Desipramine—Constipation—Etoposide—uterine cancer	0.000251	0.00181	CcSEcCtD
Desipramine—HRH1—lymph node—uterine cancer	0.000248	0.00302	CbGeAlD
Desipramine—Pollakiuria—Doxorubicin—uterine cancer	0.000247	0.00179	CcSEcCtD
Desipramine—Weight increased—Doxorubicin—uterine cancer	0.000244	0.00176	CcSEcCtD
Desipramine—Feeling abnormal—Etoposide—uterine cancer	0.000242	0.00175	CcSEcCtD
Desipramine—Nausea—Dactinomycin—uterine cancer	0.000241	0.00174	CcSEcCtD
Desipramine—Agranulocytosis—Epirubicin—uterine cancer	0.000241	0.00174	CcSEcCtD
Desipramine—Drowsiness—Doxorubicin—uterine cancer	0.000239	0.00172	CcSEcCtD
Desipramine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000234	0.00169	CcSEcCtD
Desipramine—Urticaria—Etoposide—uterine cancer	0.000233	0.00168	CcSEcCtD
Desipramine—Stomatitis—Doxorubicin—uterine cancer	0.000233	0.00168	CcSEcCtD
Desipramine—Jaundice—Doxorubicin—uterine cancer	0.000233	0.00168	CcSEcCtD
Desipramine—ABCB1—female reproductive system—uterine cancer	0.000232	0.00282	CbGeAlD
Desipramine—Abdominal pain—Etoposide—uterine cancer	0.000232	0.00168	CcSEcCtD
Desipramine—Body temperature increased—Etoposide—uterine cancer	0.000232	0.00168	CcSEcCtD
Desipramine—Hepatitis—Epirubicin—uterine cancer	0.000232	0.00167	CcSEcCtD
Desipramine—Hypoaesthesia—Epirubicin—uterine cancer	0.000231	0.00166	CcSEcCtD
Desipramine—Agranulocytosis—Doxorubicin—uterine cancer	0.000223	0.00161	CcSEcCtD
Desipramine—Tinnitus—Epirubicin—uterine cancer	0.000216	0.00156	CcSEcCtD
Desipramine—Benazepril—MTHFR—uterine cancer	0.000215	1	CrCbGaD
Desipramine—Flushing—Epirubicin—uterine cancer	0.000215	0.00155	CcSEcCtD
Desipramine—Hepatitis—Doxorubicin—uterine cancer	0.000214	0.00155	CcSEcCtD
Desipramine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000213	0.00154	CcSEcCtD
Desipramine—ABCB1—female gonad—uterine cancer	0.000211	0.00257	CbGeAlD
Desipramine—Asthenia—Etoposide—uterine cancer	0.000211	0.00152	CcSEcCtD
Desipramine—ABCB1—vagina—uterine cancer	0.00021	0.00255	CbGeAlD
Desipramine—Pruritus—Etoposide—uterine cancer	0.000208	0.0015	CcSEcCtD
Desipramine—Arrhythmia—Epirubicin—uterine cancer	0.000207	0.00149	CcSEcCtD
Desipramine—Alopecia—Epirubicin—uterine cancer	0.000205	0.00148	CcSEcCtD
Desipramine—Diarrhoea—Etoposide—uterine cancer	0.000201	0.00145	CcSEcCtD
Desipramine—Tinnitus—Doxorubicin—uterine cancer	0.0002	0.00144	CcSEcCtD
Desipramine—Flushing—Doxorubicin—uterine cancer	0.000199	0.00144	CcSEcCtD
Desipramine—Dysgeusia—Epirubicin—uterine cancer	0.000198	0.00143	CcSEcCtD
Desipramine—Dizziness—Etoposide—uterine cancer	0.000194	0.0014	CcSEcCtD
Desipramine—Arrhythmia—Doxorubicin—uterine cancer	0.000192	0.00138	CcSEcCtD
Desipramine—Vision blurred—Epirubicin—uterine cancer	0.00019	0.00137	CcSEcCtD
Desipramine—Alopecia—Doxorubicin—uterine cancer	0.000189	0.00137	CcSEcCtD
Desipramine—Ill-defined disorder—Epirubicin—uterine cancer	0.000187	0.00135	CcSEcCtD
Desipramine—Vomiting—Etoposide—uterine cancer	0.000187	0.00135	CcSEcCtD
Desipramine—Agitation—Epirubicin—uterine cancer	0.000185	0.00134	CcSEcCtD
Desipramine—Rash—Etoposide—uterine cancer	0.000185	0.00134	CcSEcCtD
Desipramine—Dermatitis—Etoposide—uterine cancer	0.000185	0.00134	CcSEcCtD
Desipramine—Headache—Etoposide—uterine cancer	0.000184	0.00133	CcSEcCtD
Desipramine—Dysgeusia—Doxorubicin—uterine cancer	0.000183	0.00132	CcSEcCtD
Desipramine—Malaise—Epirubicin—uterine cancer	0.000182	0.00131	CcSEcCtD
Desipramine—Palpitations—Epirubicin—uterine cancer	0.000178	0.00129	CcSEcCtD
Desipramine—Vision blurred—Doxorubicin—uterine cancer	0.000176	0.00127	CcSEcCtD
Desipramine—Convulsion—Epirubicin—uterine cancer	0.000175	0.00126	CcSEcCtD
Desipramine—Nausea—Etoposide—uterine cancer	0.000174	0.00126	CcSEcCtD
Desipramine—Hypertension—Epirubicin—uterine cancer	0.000174	0.00126	CcSEcCtD
Desipramine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000173	0.00125	CcSEcCtD
Desipramine—Agitation—Doxorubicin—uterine cancer	0.000172	0.00124	CcSEcCtD
Desipramine—Anxiety—Epirubicin—uterine cancer	0.000171	0.00124	CcSEcCtD
Desipramine—Discomfort—Epirubicin—uterine cancer	0.00017	0.00123	CcSEcCtD
Desipramine—Malaise—Doxorubicin—uterine cancer	0.000168	0.00122	CcSEcCtD
Desipramine—Dry mouth—Epirubicin—uterine cancer	0.000168	0.00121	CcSEcCtD
Desipramine—Confusional state—Epirubicin—uterine cancer	0.000166	0.0012	CcSEcCtD
Desipramine—Palpitations—Doxorubicin—uterine cancer	0.000165	0.00119	CcSEcCtD
Desipramine—Oedema—Epirubicin—uterine cancer	0.000165	0.00119	CcSEcCtD
Desipramine—Convulsion—Doxorubicin—uterine cancer	0.000162	0.00117	CcSEcCtD
Desipramine—Thrombocytopenia—Epirubicin—uterine cancer	0.000161	0.00116	CcSEcCtD
Desipramine—Hypertension—Doxorubicin—uterine cancer	0.000161	0.00116	CcSEcCtD
Desipramine—Tachycardia—Epirubicin—uterine cancer	0.000161	0.00116	CcSEcCtD
Desipramine—Anxiety—Doxorubicin—uterine cancer	0.000158	0.00114	CcSEcCtD
Desipramine—Discomfort—Doxorubicin—uterine cancer	0.000157	0.00113	CcSEcCtD
Desipramine—Anorexia—Epirubicin—uterine cancer	0.000157	0.00113	CcSEcCtD
Desipramine—Dry mouth—Doxorubicin—uterine cancer	0.000155	0.00112	CcSEcCtD
Desipramine—Hypotension—Epirubicin—uterine cancer	0.000154	0.00111	CcSEcCtD
Desipramine—Confusional state—Doxorubicin—uterine cancer	0.000154	0.00111	CcSEcCtD
Desipramine—Oedema—Doxorubicin—uterine cancer	0.000152	0.0011	CcSEcCtD
Desipramine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000149	0.00108	CcSEcCtD
Desipramine—Insomnia—Epirubicin—uterine cancer	0.000149	0.00108	CcSEcCtD
Desipramine—Tachycardia—Doxorubicin—uterine cancer	0.000149	0.00107	CcSEcCtD
Desipramine—Paraesthesia—Epirubicin—uterine cancer	0.000148	0.00107	CcSEcCtD
Desipramine—Somnolence—Epirubicin—uterine cancer	0.000146	0.00106	CcSEcCtD
Desipramine—Anorexia—Doxorubicin—uterine cancer	0.000145	0.00105	CcSEcCtD
Desipramine—Dyspepsia—Epirubicin—uterine cancer	0.000145	0.00105	CcSEcCtD
Desipramine—Decreased appetite—Epirubicin—uterine cancer	0.000143	0.00103	CcSEcCtD
Desipramine—Hypotension—Doxorubicin—uterine cancer	0.000142	0.00103	CcSEcCtD
Desipramine—Fatigue—Epirubicin—uterine cancer	0.000142	0.00102	CcSEcCtD
Desipramine—Constipation—Epirubicin—uterine cancer	0.000141	0.00102	CcSEcCtD
Desipramine—Insomnia—Doxorubicin—uterine cancer	0.000138	0.000995	CcSEcCtD
Desipramine—Paraesthesia—Doxorubicin—uterine cancer	0.000137	0.000988	CcSEcCtD
Desipramine—ABCB1—lymph node—uterine cancer	0.000136	0.00165	CbGeAlD
Desipramine—Feeling abnormal—Epirubicin—uterine cancer	0.000136	0.00098	CcSEcCtD
Desipramine—Somnolence—Doxorubicin—uterine cancer	0.000135	0.000978	CcSEcCtD
Desipramine—Dyspepsia—Doxorubicin—uterine cancer	0.000134	0.000968	CcSEcCtD
Desipramine—Decreased appetite—Doxorubicin—uterine cancer	0.000132	0.000956	CcSEcCtD
Desipramine—Fatigue—Doxorubicin—uterine cancer	0.000131	0.000948	CcSEcCtD
Desipramine—Urticaria—Epirubicin—uterine cancer	0.000131	0.000944	CcSEcCtD
Desipramine—Constipation—Doxorubicin—uterine cancer	0.00013	0.000941	CcSEcCtD
Desipramine—Abdominal pain—Epirubicin—uterine cancer	0.00013	0.00094	CcSEcCtD
Desipramine—Body temperature increased—Epirubicin—uterine cancer	0.00013	0.00094	CcSEcCtD
Desipramine—Feeling abnormal—Doxorubicin—uterine cancer	0.000126	0.000906	CcSEcCtD
Desipramine—Urticaria—Doxorubicin—uterine cancer	0.000121	0.000874	CcSEcCtD
Desipramine—Abdominal pain—Doxorubicin—uterine cancer	0.00012	0.000869	CcSEcCtD
Desipramine—Body temperature increased—Doxorubicin—uterine cancer	0.00012	0.000869	CcSEcCtD
Desipramine—Asthenia—Epirubicin—uterine cancer	0.000118	0.000853	CcSEcCtD
Desipramine—Pruritus—Epirubicin—uterine cancer	0.000116	0.000841	CcSEcCtD
Desipramine—Diarrhoea—Epirubicin—uterine cancer	0.000113	0.000813	CcSEcCtD
Desipramine—Asthenia—Doxorubicin—uterine cancer	0.000109	0.000789	CcSEcCtD
Desipramine—Dizziness—Epirubicin—uterine cancer	0.000109	0.000786	CcSEcCtD
Desipramine—Pruritus—Doxorubicin—uterine cancer	0.000108	0.000778	CcSEcCtD
Desipramine—Vomiting—Epirubicin—uterine cancer	0.000105	0.000756	CcSEcCtD
Desipramine—Diarrhoea—Doxorubicin—uterine cancer	0.000104	0.000753	CcSEcCtD
Desipramine—Rash—Epirubicin—uterine cancer	0.000104	0.00075	CcSEcCtD
Desipramine—Dermatitis—Epirubicin—uterine cancer	0.000104	0.000749	CcSEcCtD
Desipramine—Headache—Epirubicin—uterine cancer	0.000103	0.000745	CcSEcCtD
Desipramine—Dizziness—Doxorubicin—uterine cancer	0.000101	0.000727	CcSEcCtD
Desipramine—Nausea—Epirubicin—uterine cancer	9.78e-05	0.000706	CcSEcCtD
Desipramine—Vomiting—Doxorubicin—uterine cancer	9.68e-05	0.000699	CcSEcCtD
Desipramine—Rash—Doxorubicin—uterine cancer	9.6e-05	0.000694	CcSEcCtD
Desipramine—Dermatitis—Doxorubicin—uterine cancer	9.6e-05	0.000693	CcSEcCtD
Desipramine—Headache—Doxorubicin—uterine cancer	9.54e-05	0.000689	CcSEcCtD
Desipramine—Nausea—Doxorubicin—uterine cancer	9.05e-05	0.000653	CcSEcCtD
Desipramine—CHRM2—Signaling Pathways—CCL2—uterine cancer	5.88e-06	0.000106	CbGpPWpGaD
Desipramine—CHRM5—Signaling by GPCR—AKT1—uterine cancer	5.87e-06	0.000105	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PTEN—uterine cancer	5.86e-06	0.000105	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—PIK3CA—uterine cancer	5.85e-06	0.000105	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—ERBB2—uterine cancer	5.78e-06	0.000104	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—MTHFR—uterine cancer	5.76e-06	0.000103	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—ERBB2—uterine cancer	5.75e-06	0.000103	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.74e-06	0.000103	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—EP300—uterine cancer	5.73e-06	0.000103	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CXCL8—uterine cancer	5.73e-06	0.000103	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—HRAS—uterine cancer	5.69e-06	0.000102	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—PIK3CA—uterine cancer	5.69e-06	0.000102	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—VEGFA—uterine cancer	5.67e-06	0.000102	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—KRAS—uterine cancer	5.62e-06	0.000101	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CXCL8—uterine cancer	5.6e-06	0.000101	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—NRAS—uterine cancer	5.6e-06	0.000101	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—PIK3CA—uterine cancer	5.6e-06	0.000101	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CDKN1B—uterine cancer	5.59e-06	0.0001	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—EP300—uterine cancer	5.59e-06	0.0001	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—PIK3CA—uterine cancer	5.59e-06	0.0001	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—PIK3CA—uterine cancer	5.57e-06	0.0001	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—HRAS—uterine cancer	5.57e-06	0.0001	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—PIK3CA—uterine cancer	5.55e-06	9.97e-05	CbGpPWpGaD
Desipramine—ADRB1—GPCR downstream signaling—AKT1—uterine cancer	5.53e-06	9.94e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—KRAS—uterine cancer	5.53e-06	9.94e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—KRAS—uterine cancer	5.52e-06	9.91e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—KRAS—uterine cancer	5.5e-06	9.88e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—PIK3CA—uterine cancer	5.5e-06	9.87e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—KRAS—uterine cancer	5.49e-06	9.85e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CXCL8—uterine cancer	5.48e-06	9.84e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—uterine cancer	5.47e-06	9.83e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CDKN1B—uterine cancer	5.47e-06	9.83e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PTEN—uterine cancer	5.46e-06	9.81e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CXCL8—uterine cancer	5.45e-06	9.79e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—HRAS—uterine cancer	5.44e-06	9.78e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—KRAS—uterine cancer	5.43e-06	9.76e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—VEGFA—uterine cancer	5.43e-06	9.75e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—MTHFR—uterine cancer	5.42e-06	9.74e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—HRAS—uterine cancer	5.42e-06	9.73e-05	CbGpPWpGaD
Desipramine—ADRB2—GPCR downstream signaling—AKT1—uterine cancer	5.41e-06	9.72e-05	CbGpPWpGaD
Desipramine—SLC22A3—Metabolism—AKT1—uterine cancer	5.39e-06	9.67e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PTEN—uterine cancer	5.38e-06	9.66e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—NRAS—uterine cancer	5.36e-06	9.63e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CDKN1B—uterine cancer	5.35e-06	9.61e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CDKN1B—uterine cancer	5.32e-06	9.56e-05	CbGpPWpGaD
Desipramine—HTR1A—GPCR downstream signaling—AKT1—uterine cancer	5.29e-06	9.5e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—CTNNB1—uterine cancer	5.28e-06	9.49e-05	CbGpPWpGaD
Desipramine—HTR2C—GPCR downstream signaling—AKT1—uterine cancer	5.27e-06	9.46e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—EP300—uterine cancer	5.21e-06	9.36e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	5.2e-06	9.33e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—CTNNB1—uterine cancer	5.17e-06	9.28e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—PIK3CA—uterine cancer	5.17e-06	9.28e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PTEN—uterine cancer	5.15e-06	9.25e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—EP300—uterine cancer	5.13e-06	9.22e-05	CbGpPWpGaD
Desipramine—CYP2C18—Metabolism—AKT1—uterine cancer	5.09e-06	9.14e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—PIK3CA—uterine cancer	5.08e-06	9.13e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—ERBB2—uterine cancer	5.07e-06	9.11e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—PIK3CA—uterine cancer	5.07e-06	9.11e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—PIK3CA—uterine cancer	5.06e-06	9.08e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—CTNNB1—uterine cancer	5.05e-06	9.08e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PTEN—uterine cancer	5.05e-06	9.06e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—PIK3CA—uterine cancer	5.04e-06	9.05e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PTEN—uterine cancer	5.04e-06	9.05e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—CTNNB1—uterine cancer	5.03e-06	9.03e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling by GPCR—AKT1—uterine cancer	5.03e-06	9.02e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—ERBB2—uterine cancer	4.99e-06	8.96e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—PIK3CA—uterine cancer	4.99e-06	8.96e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—ERBB2—uterine cancer	4.98e-06	8.94e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—ERBB2—uterine cancer	4.96e-06	8.92e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—ERBB2—uterine cancer	4.95e-06	8.89e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PTEN—uterine cancer	4.93e-06	8.85e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling by GPCR—AKT1—uterine cancer	4.92e-06	8.83e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—EP300—uterine cancer	4.91e-06	8.82e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PTEN—uterine cancer	4.9e-06	8.8e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—ERBB2—uterine cancer	4.9e-06	8.8e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—KRAS—uterine cancer	4.82e-06	8.66e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—EP300—uterine cancer	4.81e-06	8.64e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CXCL8—uterine cancer	4.81e-06	8.64e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling by GPCR—AKT1—uterine cancer	4.81e-06	8.63e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—EP300—uterine cancer	4.81e-06	8.63e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling by GPCR—AKT1—uterine cancer	4.78e-06	8.59e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—HRAS—uterine cancer	4.78e-06	8.58e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CXCL8—uterine cancer	4.73e-06	8.5e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CXCL8—uterine cancer	4.72e-06	8.48e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—STK11—uterine cancer	4.72e-06	8.48e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—CYP19A1—uterine cancer	4.72e-06	8.48e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CXCL8—uterine cancer	4.71e-06	8.45e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—HRAS—uterine cancer	4.7e-06	8.45e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—EP300—uterine cancer	4.7e-06	8.44e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CDKN1B—uterine cancer	4.7e-06	8.44e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CXCL8—uterine cancer	4.69e-06	8.43e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—HRAS—uterine cancer	4.69e-06	8.43e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—HRAS—uterine cancer	4.68e-06	8.4e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—EP300—uterine cancer	4.67e-06	8.39e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—HRAS—uterine cancer	4.66e-06	8.37e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—VEGFA—uterine cancer	4.65e-06	8.35e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CXCL8—uterine cancer	4.65e-06	8.35e-05	CbGpPWpGaD
Desipramine—DRD2—GPCR downstream signaling—AKT1—uterine cancer	4.65e-06	8.35e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CDKN1B—uterine cancer	4.62e-06	8.3e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—HRAS—uterine cancer	4.62e-06	8.29e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—KRAS—uterine cancer	4.62e-06	8.29e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CDKN1B—uterine cancer	4.61e-06	8.28e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CDKN1B—uterine cancer	4.6e-06	8.26e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—NRAS—uterine cancer	4.6e-06	8.25e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—MTHFR—uterine cancer	4.6e-06	8.25e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CDKN1B—uterine cancer	4.58e-06	8.23e-05	CbGpPWpGaD
Desipramine—HTR2A—GPCR downstream signaling—AKT1—uterine cancer	4.57e-06	8.21e-05	CbGpPWpGaD
Desipramine—HRH1—GPCR downstream signaling—AKT1—uterine cancer	4.56e-06	8.19e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—VEGFA—uterine cancer	4.55e-06	8.17e-05	CbGpPWpGaD
Desipramine—CHRM1—GPCR downstream signaling—AKT1—uterine cancer	4.55e-06	8.17e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CDKN1B—uterine cancer	4.54e-06	8.15e-05	CbGpPWpGaD
Desipramine—CHRM3—GPCR downstream signaling—AKT1—uterine cancer	4.53e-06	8.14e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—NRAS—uterine cancer	4.5e-06	8.07e-05	CbGpPWpGaD
Desipramine—CHRM2—GPCR downstream signaling—AKT1—uterine cancer	4.49e-06	8.06e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—VEGFA—uterine cancer	4.45e-06	7.99e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—CTNNB1—uterine cancer	4.44e-06	7.97e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—PIK3CA—uterine cancer	4.43e-06	7.95e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—VEGFA—uterine cancer	4.43e-06	7.95e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—NRAS—uterine cancer	4.4e-06	7.89e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—NRAS—uterine cancer	4.37e-06	7.85e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—CTNNB1—uterine cancer	4.37e-06	7.84e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—CTNNB1—uterine cancer	4.36e-06	7.83e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—CTNNB1—uterine cancer	4.34e-06	7.8e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PTEN—uterine cancer	4.34e-06	7.8e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—CTNNB1—uterine cancer	4.33e-06	7.78e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PTEN—uterine cancer	4.33e-06	7.77e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—CTNNB1—uterine cancer	4.29e-06	7.7e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—TP53—uterine cancer	4.29e-06	7.69e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PTEN—uterine cancer	4.26e-06	7.64e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PTEN—uterine cancer	4.25e-06	7.64e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PTEN—uterine cancer	4.25e-06	7.63e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—PIK3CA—uterine cancer	4.24e-06	7.62e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PTEN—uterine cancer	4.23e-06	7.6e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling by GPCR—AKT1—uterine cancer	4.22e-06	7.58e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PTEN—uterine cancer	4.22e-06	7.58e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PTEN—uterine cancer	4.18e-06	7.5e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling by GPCR—AKT1—uterine cancer	4.15e-06	7.46e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling by GPCR—AKT1—uterine cancer	4.14e-06	7.44e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—EP300—uterine cancer	4.14e-06	7.44e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—PIK3CA—uterine cancer	4.14e-06	7.43e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling by GPCR—AKT1—uterine cancer	4.13e-06	7.42e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—EP300—uterine cancer	4.13e-06	7.41e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling by GPCR—AKT1—uterine cancer	4.12e-06	7.39e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—TP53—uterine cancer	4.1e-06	7.37e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—HRAS—uterine cancer	4.1e-06	7.36e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling by GPCR—AKT1—uterine cancer	4.08e-06	7.32e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—EP300—uterine cancer	4.06e-06	7.29e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—EP300—uterine cancer	4.06e-06	7.28e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—EP300—uterine cancer	4.05e-06	7.27e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	4.05e-06	7.27e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—EP300—uterine cancer	4.04e-06	7.25e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—EP300—uterine cancer	4.02e-06	7.23e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—EP300—uterine cancer	3.99e-06	7.16e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—KRAS—uterine cancer	3.96e-06	7.1e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—HRAS—uterine cancer	3.92e-06	7.05e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—VEGFA—uterine cancer	3.91e-06	7.02e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—KRAS—uterine cancer	3.87e-06	6.95e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—NRAS—uterine cancer	3.86e-06	6.93e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—PIK3CA—uterine cancer	3.85e-06	6.92e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—VEGFA—uterine cancer	3.84e-06	6.9e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—VEGFA—uterine cancer	3.84e-06	6.89e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—VEGFA—uterine cancer	3.82e-06	6.87e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—VEGFA—uterine cancer	3.81e-06	6.84e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—NRAS—uterine cancer	3.8e-06	6.82e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—PIK3CA—uterine cancer	3.8e-06	6.82e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—NRAS—uterine cancer	3.79e-06	6.8e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—KRAS—uterine cancer	3.78e-06	6.79e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—NRAS—uterine cancer	3.78e-06	6.78e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—VEGFA—uterine cancer	3.77e-06	6.78e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—NRAS—uterine cancer	3.77e-06	6.76e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—KRAS—uterine cancer	3.76e-06	6.76e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—NRAS—uterine cancer	3.73e-06	6.7e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—PIK3CA—uterine cancer	3.63e-06	6.53e-05	CbGpPWpGaD
Desipramine—CHRM4—Signaling Pathways—AKT1—uterine cancer	3.62e-06	6.5e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—PIK3CA—uterine cancer	3.56e-06	6.39e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—PIK3CA—uterine cancer	3.55e-06	6.38e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—MTHFR—uterine cancer	3.55e-06	6.37e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—TP53—uterine cancer	3.52e-06	6.31e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—PIK3CA—uterine cancer	3.48e-06	6.24e-05	CbGpPWpGaD
Desipramine—CHRM5—Signaling Pathways—AKT1—uterine cancer	3.47e-06	6.22e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—PIK3CA—uterine cancer	3.46e-06	6.21e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—TP53—uterine cancer	3.44e-06	6.18e-05	CbGpPWpGaD
Desipramine—SLC22A2—Metabolism—AKT1—uterine cancer	3.38e-06	6.07e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—TP53—uterine cancer	3.36e-06	6.04e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—HRAS—uterine cancer	3.36e-06	6.04e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—TP53—uterine cancer	3.35e-06	6.01e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—KRAS—uterine cancer	3.32e-06	5.96e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—HRAS—uterine cancer	3.29e-06	5.91e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PTEN—uterine cancer	3.28e-06	5.89e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—KRAS—uterine cancer	3.27e-06	5.87e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—KRAS—uterine cancer	3.26e-06	5.86e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—KRAS—uterine cancer	3.25e-06	5.84e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—KRAS—uterine cancer	3.24e-06	5.82e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—HRAS—uterine cancer	3.22e-06	5.77e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—KRAS—uterine cancer	3.21e-06	5.76e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PTEN—uterine cancer	3.2e-06	5.75e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—HRAS—uterine cancer	3.2e-06	5.74e-05	CbGpPWpGaD
Desipramine—SLC22A1—Metabolism—AKT1—uterine cancer	3.15e-06	5.65e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—EP300—uterine cancer	3.13e-06	5.62e-05	CbGpPWpGaD
Desipramine—CYP2A6—Metabolism—AKT1—uterine cancer	3.1e-06	5.57e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—PIK3CA—uterine cancer	3.06e-06	5.5e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—EP300—uterine cancer	3.05e-06	5.48e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—PIK3CA—uterine cancer	3.05e-06	5.48e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PTEN—uterine cancer	3.02e-06	5.42e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—PIK3CA—uterine cancer	3e-06	5.39e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—PIK3CA—uterine cancer	3e-06	5.39e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—PIK3CA—uterine cancer	3e-06	5.38e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—PIK3CA—uterine cancer	2.99e-06	5.36e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—PIK3CA—uterine cancer	2.98e-06	5.35e-05	CbGpPWpGaD
Desipramine—ADRB1—Signaling Pathways—AKT1—uterine cancer	2.97e-06	5.33e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—TP53—uterine cancer	2.95e-06	5.3e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—PIK3CA—uterine cancer	2.95e-06	5.29e-05	CbGpPWpGaD
Desipramine—CHRM3—Metabolism—AKT1—uterine cancer	2.91e-06	5.22e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—TP53—uterine cancer	2.9e-06	5.22e-05	CbGpPWpGaD
Desipramine—ADRB2—Signaling Pathways—AKT1—uterine cancer	2.9e-06	5.21e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—TP53—uterine cancer	2.9e-06	5.21e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—TP53—uterine cancer	2.89e-06	5.19e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—TP53—uterine cancer	2.88e-06	5.17e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—EP300—uterine cancer	2.88e-06	5.17e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—TP53—uterine cancer	2.85e-06	5.12e-05	CbGpPWpGaD
Desipramine—HTR1A—Signaling Pathways—AKT1—uterine cancer	2.84e-06	5.1e-05	CbGpPWpGaD
Desipramine—HTR2C—Signaling Pathways—AKT1—uterine cancer	2.82e-06	5.07e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—HRAS—uterine cancer	2.82e-06	5.07e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—HRAS—uterine cancer	2.78e-06	4.99e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—HRAS—uterine cancer	2.77e-06	4.98e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—HRAS—uterine cancer	2.76e-06	4.96e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—HRAS—uterine cancer	2.75e-06	4.95e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—HRAS—uterine cancer	2.73e-06	4.9e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PTEN—uterine cancer	2.56e-06	4.59e-05	CbGpPWpGaD
Desipramine—CYP2B6—Metabolism—AKT1—uterine cancer	2.5e-06	4.49e-05	CbGpPWpGaD
Desipramine—DRD2—Signaling Pathways—AKT1—uterine cancer	2.49e-06	4.48e-05	CbGpPWpGaD
Desipramine—HTR2A—Signaling Pathways—AKT1—uterine cancer	2.45e-06	4.4e-05	CbGpPWpGaD
Desipramine—CYP2E1—Metabolism—AKT1—uterine cancer	2.45e-06	4.4e-05	CbGpPWpGaD
Desipramine—HRH1—Signaling Pathways—AKT1—uterine cancer	2.45e-06	4.4e-05	CbGpPWpGaD
Desipramine—CHRM1—Signaling Pathways—AKT1—uterine cancer	2.44e-06	4.38e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—EP300—uterine cancer	2.44e-06	4.38e-05	CbGpPWpGaD
Desipramine—CHRM3—Signaling Pathways—AKT1—uterine cancer	2.43e-06	4.37e-05	CbGpPWpGaD
Desipramine—CHRM2—Signaling Pathways—AKT1—uterine cancer	2.41e-06	4.33e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—PIK3CA—uterine cancer	2.31e-06	4.16e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—PIK3CA—uterine cancer	2.26e-06	4.06e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—PIK3CA—uterine cancer	2.13e-06	3.82e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PTEN—uterine cancer	1.97e-06	3.54e-05	CbGpPWpGaD
Desipramine—CYP2C19—Metabolism—AKT1—uterine cancer	1.89e-06	3.4e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—EP300—uterine cancer	1.88e-06	3.38e-05	CbGpPWpGaD
Desipramine—ABCB1—Metabolism—AKT1—uterine cancer	1.85e-06	3.31e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—PIK3CA—uterine cancer	1.8e-06	3.24e-05	CbGpPWpGaD
Desipramine—CYP2D6—Metabolism—AKT1—uterine cancer	1.74e-06	3.12e-05	CbGpPWpGaD
Desipramine—CYP1A2—Metabolism—AKT1—uterine cancer	1.47e-06	2.65e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—PIK3CA—uterine cancer	1.39e-06	2.5e-05	CbGpPWpGaD
Desipramine—CYP3A4—Metabolism—AKT1—uterine cancer	1.14e-06	2.04e-05	CbGpPWpGaD
